보균자 검사 시장 - 세계 산업 규모, 점유율, 동향, 기회 및 예측, 유형별, 스크리닝 유형별, 기술별, 적응증별, 최종 사용자별, 기업별, 지역별(2017-2027년)
Carrier Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Type, By Screening Type, By Technology, By Indication, By End User, By Company, and By Region
세계 보균자 검사 시장은 2023-2027년의 예측 기간 동안 괄목할 만한 성장세를 보일 것으로 예상됩니다.
유전성 질환 증가, 조기 발견 및 예방에 대한 중요성 증가, 유전체학 분야의 기술 발전 등이 시장 성장의 주요 요인으로 꼽힙니다. 유전성 질환은 정상적인 DNA 염기서열의 돌연변이로 인해 발생하는 질환을 말합니다. 유전질환을 가진 자녀를 낳을 위험을 파악하는 데 도움이 되는 검사의 일종인 보인자 검사는 유전질환을 가진 자녀를 낳을 수 있는 위험을 알려줍니다. 건강한 사람이 겸상적혈구증, 낭포성 섬유증과 같은 유전성 질환의 열성 유전자를 가지고 있는지 여부를 판단하는 것입니다. 기타 시장 개척 요인으로는 정부의 연구개발 활동에 대한 투자 증가, 새로운 유전자 검사법 출시 및 승인 증가, 세계 출산율 증가, 맞춤형 의료에 대한 관심 증가, 유전자 검사에 대한 대중의 인식 증가, 산모의 연령 증가, 대량 유전자 검사 프로그램 이용, 높은 염색체 이상 발생률 등을 들 수 있습니다.
유전성 질환의 유병률 증가
유전자 및 염색체 돌연변이로 인한 유전성 질환과 태아의 염색체 이상 발생률이 증가하면서 세계 시장 성장을 견인하고 있습니다. 예를 들어, 미국에서는 유전성 질환이 신생아 사망의 주요 원인으로 연간 영아 사망의 20%에 육박하는 것으로 나타났습니다. 낭포성 섬유증, 테이삭스병, 겸상 적혈구 빈혈과 같은 유전성 질환은 부모의 유전성 질환으로 인해 발생하여 자손에게 유전될 수 있습니다. 세계보건기구(WHO)에 따르면, 2019년 기준 약 2-5%의 유아가 유전성 질환이나 염색체 이상을 가지고 있는 것으로 추정됩니다. 신생아에서 장애 발생이 증가함에 따라 산전 검사에 대한 수요가 급증하면서 시장 성장을 견인하고 있습니다.
복잡한 유전성 질환의 조기 발견과 예방의 중요성 증대
최근 몇 년동안 유전성 질환에 대한 인식이 높아져 계획적으로 아기를 돌볼 수 있게 되었습니다. 도시 부모들이 출산을 늦추려는 경향이 강해지고, 산모의 평균 연령이 높아지면서 임신 합병증에 대한 우려가 높아진 것도 시장 성장에 영향을 미치고 있습니다. 조기 발견을 통해 부부는 임신 초기에 유전성 질환이나 장애를 가진 아이를 낳을 위험을 알 수 있습니다. 이처럼 복잡한 유전성 질환의 조기 발견과 예방에 대한 관심이 높아지면서 세계적으로 시장 성장을 견인하고 있습니다. 조기 경력 선별을 위해 정부 및 비정부 기관에서 다양한 노력을 기울이고 있습니다. 예를 들어, 2018년 두바이 보건당국은 '스텝원 신생아 선별검사'를 도입했습니다.
기술 발전이 시장 성장을 가속
유전체 분야의 첨단 기술 도입이 증가하면서 시장 성장을 강화하고 있습니다. 보균자 검사 방법의 기술 발전으로 검사 기술의 신뢰성과 편의성이 향상되고 있습니다. 예를 들어, 2022년 미국의 과학 제품 공급업체인 Thermo Fisher Scientific Inc.는 유전자 발현을 포함한 유전자 장애를 검사하는 데 도움이 되는 단일 솔루션 보균자 검사 방법의 일종인 NGS 기반 테스트 키트를 출시할 것이라고 발표했습니다. 발표했습니다.
사용자 지정 가능
TechSci Research는 주어진 시장 데이터를 기반으로 기업의 특정 요구에 따라 맞춤화를 제공합니다. 본 보고서에서는 다음과 같은 커스터마이징이 가능합니다.
기업 소개
- 추가 시장 기업에 대한 상세한 분석 및 프로파일링(최대 5개 기업).
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 COVID-19가 세계 보균자 검사 시장에 미치는 영향
제5장 VOC(고객의 소리)
제6장 세계의 보균자 검사 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 유형별(확장 보균자 검사 vs 타겟 암 선별검사)
- 스크리닝 유형별(산전 보균자 검사/임신 전 보균자 검사)
- 기술별(차세대 시퀸싱, 중합효소 연쇄반응, 마이크로어레이, 기타)
- 적응증별(낭포성 섬유증, 다운증후군, 지중해빈혈, 테이삭스병, 헌팅턴병, 겸상 적혈구 빈혈, 기타)
- 최종사용자별(병원 및 클리닉, 참조 실험실, 기타)
- 지역별
- 기업별(2021년)
- 시장 맵
제7장 북미의 보균자 검사 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 유형별
- 스크리닝 유형별
- 기술별
- 적응증별
- 최종사용자별
- 국가별
- 북미 국가별 분석
제8장 유럽의 보균자 검사 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 유형별
- 스크리닝 유형별
- 기술별
- 적응증별
- 최종사용자별
- 국가별
- 유럽 국가별 분석
제9장 아시아태평양의 보균자 검사 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 유형별
- 스크리닝 유형별
- 기술별
- 적응증별
- 최종사용자별
- 국가별
- 아시아태평양 국가별 분석
제10장 남미의 보균자 검사 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 유형별
- 스크리닝 유형별
- 기술별
- 적응증별
- 최종사용자별
- 국가별
- 남미 : 국가별 분석
제11장 중동 및 아프리카의 보균자 검사 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 유형별
- 스크리닝 유형별
- 기술별
- 적응증별
- 최종사용자별
- 국가별
- 중동 및 아프리카(MEA) 국가별 분석
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트(UAE)
제12장 시장 역학
제13장 시장 동향과 개척
제14장 경쟁 구도(SWOT 분석 포함)
- Eurofins Scientific, Inc.
- Fulgent Genetics, Inc.
- CENTOGENE N.V.
- Invitae Corporation
- Illumina, Inc.
- Gene by Gene, Ltd.
- Laboratory Corporation of America Holdings
- Natera, Inc.
- Myriad Genetics, Inc.
- Quest Diagnostics, Inc.
제15장 전략적인 제안
LSH
The global carrier screening market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include increasing occurrences of genetic conditions, rising emphasis on early detection and prevention, and technological developments in the field of genomics that are fueling the growth of the market. Genetic conditions are diseases caused due to mutations in the normal DNA sequence. Carrier screening is a kind of test that helps to know the risk of having a child with a genetic disorder. It determines whether a healthy person contains the recessive gene of genetic diseases such as sickle cell disease, cystic fibrosis, and others. The other factors supporting the market's growth are rising investments in research and developments activities by the government, rise in numerous releases and approvals of new carrier screening tests, increasing birth rate across the globe, rising focus on personalized medicine, growing awareness of carrier screening among the population, increasing maternal age, availability of mass genetic testing programs, and the high incidence of chromosomal disorders.
Rising Prevalence of Genetic Diseases
The rising incidences of genetic disorders and fetal chromosomal anomalies due to mutation in genes or chromosomes are bolstering the growth of the market globally. For instance, in the U.S., genetic diseases are the primary cause of newborn deaths, accounting for nearly 20% of annual infant mortality. Genetic diseases such as cystic fibrosis, Tay-Sachs disease, and sickle cell anemia occur due to inheritable genetic conditions present in parents, which may get inherited by the offspring. According to the World Health Organization (WHO), in 2019, about 2 to 5% of infants had genetic diseases or chromosomal abnormalities. Owing to the increasing occurrences of disabilities in newborns, the surge in demand for prenatal testing is propelling the growth of the market.
Rising Emphasis on Early Detection and Prevention of Complex Genetic Disorders
In recent years, people have become more aware of genetic disorders, which enables them to plan and take better care of their babies. The growing inclination among urban parents to delay childbearing and the higher average age of mothers lead to pregnancy complications, which is a contributing factor to facilitating the growth of the market. Early detection helps couples to know the risk of having a child with genetic diseases or disorders in an early stage of pregnancy. Thus, the rising focus on early detection and prevention of complex genetic disorders is fueling the growth of the market globally. Various initiatives are taken by government and non-government organizations for early carrier screening. For instance, in 2018, "Step One Newborn Screening" was introduced by the Dubai health authority.
Technological Advancements fuel the Market Growth.
The rise in the adoption of advanced technology in the field of genomics sector is augmenting the growth of the market. The testing techniques are becoming more reliable and convenient because of technological advancements in carrier screening methods. For instance, in 2022, Thermo Fisher Scientific Inc., an American supplier of scientific products, announced the launch of an NGS-based test kit, which is a type of carrier screening approach in single solution that assists in scanning genetic disorders, including gene expression.
Market Segmentation
The global carrier screening market is segmented into type, screening type, technology, indication, end user, and company. Based on type, the market is divided into expanded carrier screening and targeted cancer screening. Based on screening type, the market is divided into prenatal carrier testing and preconception carrier screening. Based on technology, the market is divided into next-generation sequencing, polymerase chain reaction, microarrays, and others. Based on indication, the market is divided into cystic fibrosis, down's syndrome, thalassemia, tay sachs disease, Huntington's disease, sickle cell anemia, and others. Based on end-user, the market is divided into hospitals & clinics, reference laboratories, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the increasing incidences of genetic conditions and technological advancements in the country.
Market Players
Eurofins Scientific, Inc., Fulgent Genetics, Inc., CENTOGENE N.V., Invitae Corporation, Illumina, Inc., Gene by Gene, Ltd., Laboratory Corporation of America Holdings, Natera, Inc., Myriad Genetics, Inc., and Quest Diagnostics, Inc are some of the leading companies operating in the market.
Report Scope
In this report, global carrier screening market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Carrier Screening Market, By Type:
- Expanded Carrier Screening
- Targeted Cancer Screening
Carrier Screening Market, By Screening Type:
- Prenatal Carrier Testing
- Preconception Carrier Screening
Carrier Screening Market, By Technology:
- Next-Generation Sequencing
- Polymerase Chain Reaction
- Microarrays
- Others
Carrier Screening Market, By Indication:
- Cystic Fibrosis
- Down's Syndrome
- Thalassemia
- Tay-Sachs Disease
- Huntington's Disease
- Sickle Cell Anemia
- Others
Carrier Screening Market, By End User:
- Hospitals & Clinics
- Reference Laboratories
- Others
Carrier Screening Market, By Region:
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- Europe & CIS
- Germany
- France
- United Kingdom
- Spain
- Italy
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Turkey
- Egypt
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Carrier Screening Market
Available Customizations
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Carrier Screening Market
5. Voice of Customer
6. Global Carrier Screening Market Outlook
- 6.1. Market Size & Forecast
- 6.2. Market Share & Forecast
- 6.2.1. By Type (Expanded Carrier Screening v/s Targeted Cancer Screening)
- 6.2.2. By Screening Type (Prenatal Carrier Testing v/s Preconception Carrier Screening)
- 6.2.3. By Technology (Next Generation Sequencing, Polymerase Chain Reaction, Microarrays, Others)
- 6.2.4. By Indication (Cystic Fibrosis, Down's Syndrome, Thalassemia, Tay-Sachs Disease, Huntington's Disease, Sickle Cell Anemia, Others)
- 6.2.5. By End User (Hospitals & Clinics, Reference Laboratories, Others)
- 6.2.6. By Region
- 6.2.7. By Company (2021)
- 6.3. Market Map
7. North America Carrier Screening Market Outlook
- 7.1. Market Size & Forecast
- 7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Screening Type
- 7.2.3. By Technology
- 7.2.4. By Indication
- 7.2.5. By End User
- 7.2.6. By Country
- 7.3. North America: Country Analysis
- 7.3.1. United States Carrier Screening Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Type
- 7.3.1.2.2. By Screening Type
- 7.3.1.2.3. By Technology
- 7.3.1.2.4. By Indication
- 7.3.1.2.5. By End User
- 7.3.2. Canada Carrier Screening Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Type
- 7.3.2.2.2. By Screening Type
- 7.3.2.2.3. By Technology
- 7.3.2.2.4. By Indication
- 7.3.2.2.5. By End User
- 7.3.3. Mexico Carrier Screening Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Type
- 7.3.3.2.2. By Screening Type
- 7.3.3.2.3. By Technology
- 7.3.3.2.4. By Indication
- 7.3.3.2.5. By End User
8. Europe Carrier Screening Market Outlook
- 8.1. Market Size & Forecast
- 8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Screening Type
- 8.2.3. By Technology
- 8.2.4. By Indication
- 8.2.5. By End User
- 8.2.6. By Country
- 8.3. Europe: Country Analysis
- 8.3.1. France Carrier Screening Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Type
- 8.3.1.2.2. By Screening Type
- 8.3.1.2.3. By Technology
- 8.3.1.2.4. By Indication
- 8.3.1.2.5. By End User
- 8.3.2. Germany Carrier Screening Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Type
- 8.3.2.2.2. By Screening Type
- 8.3.2.2.3. By Technology
- 8.3.2.2.4. By Indication
- 8.3.2.2.5. By End User
- 8.3.3. United Kingdom Carrier Screening Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Type
- 8.3.3.2.2. By Screening Type
- 8.3.3.2.3. By Technology
- 8.3.3.2.4. By Indication
- 8.3.3.2.5. By End User
- 8.3.4. Italy Carrier Screening Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Type
- 8.3.4.2.2. By Screening Type
- 8.3.4.2.3. By Technology
- 8.3.4.2.4. By Indication
- 8.3.4.2.5. By End User
- 8.3.5. Spain Carrier Screening Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Type
- 8.3.5.2.2. By Screening Type
- 8.3.5.2.3. By Technology
- 8.3.5.2.4. By Indication
- 8.3.5.2.5. By End User
9. Asia-Pacific Carrier Screening Market Outlook
- 9.1. Market Size & Forecast
- 9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Screening Type
- 9.2.3. By Technology
- 9.2.4. By Indication
- 9.2.5. By End User
- 9.2.6. By Country
- 9.3. Asia-Pacific: Country Analysis
- 9.3.1. China Carrier Screening Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Type
- 9.3.1.2.2. By Screening Type
- 9.3.1.2.3. By Technology
- 9.3.1.2.4. By Indication
- 9.3.1.2.5. By End User
- 9.3.2. India Carrier Screening Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Type
- 9.3.2.2.2. By Screening Type
- 9.3.2.2.3. By Technology
- 9.3.2.2.4. By Indication
- 9.3.2.2.5. By End User
- 9.3.3. Japan Carrier Screening Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Type
- 9.3.3.2.2. By Screening Type
- 9.3.3.2.3. By Technology
- 9.3.3.2.4. By Indication
- 9.3.3.2.5. By End User
- 9.3.4. South Korea Carrier Screening Market Outlook
- 9.3.4.1. Market Size & Forecast
- 9.3.4.2. Market Share & Forecast
- 9.3.4.2.1. By Type
- 9.3.4.2.2. By Screening Type
- 9.3.4.2.3. By Technology
- 9.3.4.2.4. By Indication
- 9.3.4.2.5. By End User
- 9.3.5. Australia Carrier Screening Market Outlook
- 9.3.5.1. Market Size & Forecast
- 9.3.5.2. Market Share & Forecast
- 9.3.5.2.1. By Type
- 9.3.5.2.2. By Screening Type
- 9.3.5.2.3. By Technology
- 9.3.5.2.4. By Indication
- 9.3.5.2.5. By End User
10. South America Carrier Screening Market Outlook
- 10.1. Market Size & Forecast
- 10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Screening Type
- 10.2.3. By Technology
- 10.2.4. By Indication
- 10.2.5. By End User
- 10.2.6. By Country
- 10.3. South America: Country Analysis
- 10.3.1. Brazil Carrier Screening Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Type
- 10.3.1.2.2. By Screening Type
- 10.3.1.2.3. By Technology
- 10.3.1.2.4. By Indication
- 10.3.1.2.5. By End User
- 10.3.2. Argentina Carrier Screening Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Type
- 10.3.2.2.2. By Screening Type
- 10.3.2.2.3. By Technology
- 10.3.2.2.4. By Indication
- 10.3.2.2.5. By End User
- 10.3.3. Colombia Carrier Screening Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Type
- 10.3.3.2.2. By Screening Type
- 10.3.3.2.3. By Technology
- 10.3.3.2.4. By Indication
- 10.3.3.2.5. By End User
11. Middle East and Africa Carrier Screening Market Outlook
- 11.1. Market Size & Forecast
- 11.2. Market Share & Forecast
- 11.2.1. By Type
- 11.2.2. By Screening Type
- 11.2.3. By Technology
- 11.2.4. By Indication
- 11.2.5. By End User
- 11.2.6. By Country
- 11.3. MEA: Country Analysis
- 11.3.1. South Africa Carrier Screening Market Outlook
- 11.3.1.1. Market Size & Forecast
- 11.3.1.2. Market Share & Forecast
- 11.3.1.2.1. By Type
- 11.3.1.2.2. By Screening Type
- 11.3.1.2.3. By Technology
- 11.3.1.2.4. By Indication
- 11.3.1.2.5. By End User
- 11.3.2. Saudi Arabia Carrier Screening Market Outlook
- 11.3.2.1. Market Size & Forecast
- 11.3.2.2. Market Share & Forecast
- 11.3.2.2.1. By Type
- 11.3.2.2.2. By Screening Type
- 11.3.2.2.3. By Technology
- 11.3.2.2.4. By Indication
- 11.3.2.2.5. By End User
- 11.3.3. UAE Carrier Screening Market Outlook
- 11.3.3.1. Market Size & Forecast
- 11.3.3.2. Market Share & Forecast
- 11.3.3.2.1. By Type
- 11.3.3.2.2. By Screening Type
- 11.3.3.2.3. By Technology
- 11.3.3.2.4. By Indication
- 11.3.3.2.5. By End User
12. Market Dynamics
- 12.1. Drivers
- 12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape (Inclusive of SWOT Analysis)
- 14.1. Eurofins Scientific, Inc.
- 14.2. Fulgent Genetics, Inc.
- 14.3. CENTOGENE N.V.
- 14.4. Invitae Corporation
- 14.5. Illumina, Inc.
- 14.6. Gene by Gene, Ltd.
- 14.7. Laboratory Corporation of America Holdings
- 14.8. Natera, Inc.
- 14.9. Myriad Genetics, Inc.
- 14.10. Quest Diagnostics, Inc.
15. Strategic Recommendations
